After disappointing investors last year, the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets, and rival biotechnology ETFs are rebounding and plenty of market participants are taking notice. Up about 12.6% year-to-date, IBB continues...